1. World Health Organization: Therapeutics and COVID-19: Living Guideline, 31 March 2021 (No. WHO/2019-nCoV/therapeutics/2021.1). World Health Organization (2021)
2. World Health Organization: WHO Health Emergency Dashboard. https://covid19.who.int/. Accessed 24 May 2023
3. Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., et al.: Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19. (2020)
4. Dai, W., Zhang, B., Jiang, X.M., Su, H., Li, J., Zhao, Y., et al.: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368(6497), 1331–1335 (2020)
5. Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.L., Abiona, O., et al.: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483), 1260–1263 (2020)